cell therapies

R&D
6th Allogeneic Cell Therapies Summit banner
Partner Content

6th Allogeneic Cell Therapies Summit

The entire cell therapy field is experiencing a shift towards allogeneic platforms as the potential to achieve a truly off-the-shelf, universal, and efficacious cell therapy offers great advantages

R&D
5th TCR-based Therapies for Solid Tumors Summit banner
Partner Content

5th TCR-based Therapies for Solid Tumors Summit

In the midst of Immunocore's pioneering TCR bispecific product entering commercial markets and the $1.6 billion collaboration between Immatics and Moderna, the TCR space is witnessing a per

Oncology
CAR-TCR 2023 – Matt Lakelin

CAR-TCR 2023 – Matt Lakelin

Innovative, advanced therapies have enormous promise, but also come with a host of logistical problems that innovators underestimate at their own peril.

Oncology
CAR-TCR 2023 – Becky Cap

CAR-TCR 2023 – Becky Cap

In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder